Dr Toh Ching Han

Dr Toh Ching Han is an associate consultant at the National Cancer Centre Singapore. She obtained her undergraduate medical degree from the Lee Kong Chian School of Medicine Singapore and completed her postgraduate qualifications in Internal Medicine by the Royal College of Physicians of United Kingdom in 2021. She went on to complete her advanced specialist training in Medical Oncology and currently has clinical and research interest in breast and gynaecological cancers.

• Specialty Certificate in Medical Oncology, Royal College of Physicians, United Kingdom, 2025 
• Master of Medicine (Internal Medicine), National University of Singapore, 2022 
• MRCP (Internal Medicine), Royal College of Physicians, United Kingdom, 2021 
• MBBS, Lee Kong Chian School of Medicine, Nanyang Technological University Singapore, 2018

• Singapore Society of Oncology Member 
• American Society of Oncology Member 
• European Society of Oncology Member

• SingHealth Associate in Education Award, 2025 
• Medicine ACP Junior Educator Award, 2022 
• SingHealth Best Junior Doctor Award, 2019

• Ma, J., Chan, J.J., Toh, C.H. et al. Emerging systemic therapy options beyond CDK4/6 in-hibitors for hormone receptor-positive HER2-negative advanced breast cancer. npj Breast Cancer 9, 74 (2023). https://doi.org/10.1038/s41523-023-00578-3 
• Toh CH, Sule AA. Treatment of Deep Vein Thrombosis in May-Thurner's Syndrome with a Novel Oral Anticoagulant: A Case Report. Int J Angiol. 2019;28(4):262-266. doi:10.1055/s-0038-1661003